Characterization of the amino-terminal domain of Mx2/MxB-dependent interaction with the HIV-1 capsid

References

[1] Busnadiego I, Kane M, Rihn SJ, Preugschas HF, Hughes J, Blanco-Melo D, Strouvelle VP, Zang TM, Willett BJ, Boutell C (2014) Host and Viral Determinants of Mx2 Antiretroviral Activity. J Virol88: 7738-7752

[2] Chappie JS, Acharya S, Leonard M, Schmid SL, Dyda F (2010) G domain dimerization controls dynamin’s assembly-stimulated GTPase activity. Nature465: 435-440

[3] Fricke T, White T, Schulte B, de Souza Aranha Vieira D, Dharan A, Campbell E, Brandariz-Nunez A, Diaz-Griffero F (2014) Mx2 binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology11: 68

[4] Gao S, von der Malsburg A, Paeschke S, Behlke J, Haller O, Kochs G, Daumke O (2010) Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature465: 502-506

[5] Gao S, von der Malsburg A, Dick A, Faelber K, Schröder, Gunnar F, Haller O, Kochs G, Daumke O (2011) Structure of myxovirus resistance protein A reveals intra-and intermolecular domain interactions required for the antiviral function. Immunity35: 514-525

[6] Goujon C, Moncorge O, Bauby H, Doyle T, Ward C, Schaller T, Hue S, Barclay W, Schulz R, Malim M (2013) Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature502: 559-562

[7] Haller O, Gao S, von der Malsburg A, Daumke O, Kochs G (2010) Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity. J Biol Chem285: 28419-28424

[8] Hung M, Niedziela-Majka A, Jin D, Wong M, Leavitt S, Brendza KM, Liu X, Sakowicz R (2013) Large-scale functional purification of recombinant HIV-1 capsid. PLoS One8: e58035

[9] Kane M, Yadav S, Bitzegeio J, Kutluay S, Zang T, Wilson S, Schoggins J, Rice C, Yamashita M, Hatziioannou T (2013) MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature502: 563-566

[10] Lindenmann J (1962) Resistance of mice to mouse-adapted influenza A virus. Virology16: 203-204

[11] Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C (2013) The interferon-inducible Mx2 protein inhibits HIV-1 infection. Cell Host Microbe14: 398-410

[12] Melen K, Keskinen P, Ronni T, Sareneva T, Lounatmaa K, Julkunen I (1996) Human Mx2 protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J Biol Chem271: 23478-23486

[13] Pornillos O, Ganser-Pornillos BK, Yeager M (2011) Atomic-level modelling of the HIV capsid. Nature469: 424-427

[14] Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson D, Sundquist W, Sodroski J (2006) Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA103: 5514-5519

[15] Yang H, Ji X, Zhao G, Ning J, Zhao Q, Aiken C, Gronenborn AM, Zhang P, Xiong Y (2012) Structural insight into HIV-1 capsid recognition by rhesus TRIM5α. Proc Natl Acad Sci USA109: 18372-18377

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.